IP Verse

Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation

Patent No. EP2825654 (titled "Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation") was filed by Massachusetts Institute OF Technology on Dec 12, 2013. The application was issued on Apr 26, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MATHYS & SQUIREJan 26, 2018WILDING
COHAUSZ & FLORACK PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBBJan 26, 2018COHAUSZ & FLORACK
STRAWMANJan 25, 2018SHARP
GRUNDJan 23, 2018GRUND
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBJan 19, 2018-
SCHLICHDec 12, 2017SCHLICH
PATENT BOUTIQUEMay 16, 2017PATENT BOUTIQUE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2825654

MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Application Number
EP13812430A
Filing Date
Dec 12, 2013
Status
Revoked
Mar 19, 2025
Publication Date
Apr 26, 2017
External Links
Slate, Register , Google Patents